Hutch News

The unintended immune consequences of HIV treatments

The unintended immune consequences of HIV treatments

From the Hladik Lab, Vaccine and Infectious Disease Division
Science Spotlight - October 19, 2020
SCHARP played key role in scientific breakthrough of the year

SCHARP played key role in scientific breakthrough of the year

Science magazine selected HIV prevention trial for its top honor of 2011; study showed early antiretroviral therapy reduced heterosexual HIV transmission by 96 percent
Hutch News - January 09, 2012
Study details how long-term nonprogressors control HIV

Study details how long-term nonprogressors control HIV

Local collaborative research has far-reaching implications for autoimmunity, chronic infection control
Hutch News - July 25, 2011
Initiation of antiretroviral treatment protects partners from HIV infection

Initiation of antiretroviral treatment protects partners from HIV infection

Supported by SCHARP’s data management, HIV Prevention Trials Network shows 96 percent reduction in HIV transmission to uninfected sexual partners
Hutch News - May 23, 2011
Six-month drug regimen cuts HIV risk for breastfeeding infants

Six-month drug regimen cuts HIV risk for breastfeeding infants

SCHARP data shows longer nevirapine treatment reduces infection by half for babies with HIV-infected mothers, 75 percent for infants of untreated moms
Hutch News - March 14, 2011
Study shows ART lowers HIV transmission

Study shows ART lowers HIV transmission

Antiretroviral therapy associated with 92 percent decreased risk of HIV transmission among HIV-1 discordant couples in large, multinational study
Hutch News - June 01, 2010